Effect of oxygen supplement during hemodialysis on serum erythropoietin and hemoglobin in end stage renal disease patient
Phase 3
Recruiting
- Conditions
- End-stage renal disease,normobaric oxygen paradox
- Registration Number
- TCTR20161230004
- Lead Sponsor
- Ratchadapiseksompotch Fund
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
1)End-stage renal disease patients who had regular hemodialysis at King Chulalongkorn memorial hospital
2)Age older than 18 years
3)Stable erythropoietin supplement at least 2 months
Exclusion Criteria
1)Gastrointestinal bleeding in 3 months
2)Chronic lung diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method erythropoietin 6 weeks erythropoietin level
- Secondary Outcome Measures
Name Time Method anemia 6 weeks hemoglobin, reticulocyte count